Clinical predictors of tissue necrosis following rattlesnake envenomation

Abstract Background: Rattlesnake envenomation (RSE) causes edema, hemotoxicity and tissue necrosis. Necrosis may result in permanent disability. Objective: To study patient-related factors associated with tissue necrosis after Crotalus envenomation. Methods: Prospective cohort study of patients admitted to the Medical Toxicology service with diagnosis of RSE between April 2011 and November 2014. Inclusion criteria were age ≥18 years and upper extremity (UE) envenomation site. Primary outcome was tissue necrosis, including dermonecrosis, manifesting as bullae. Secondary outcome was amputation. Results: 77 subjects, age 18 to 88 years, met inclusion criteria. Rattlesnake species was unknown in most cases. All received Fab antivenom. 62 (82%) had a digital envenomation. 31 (40.3%) had necrosis. Necrotic area ranged from 0.1 cm2 to 14 cm2. Procedural interventions, (superficial debridement, dermotomy, surgical exploration, and operative debridement of devitalized tissue) occurred in 25 (32.5%). Five (6.5%) underwent dermotomy and 6 (7.8%) operative debridement. No amputations were performed. Patients with cyanosis on presentation had increased risk of developing necrosis (11/12; RR 2.98 95% CI 1.99–4.46). Ecchymosis on presentation was also associated with increased risk of necrosis (24/32; RR 4.04 95% CI 2.08–7.86). Patients with social or regular ethanol use were more likely to develop necrosis than those without (28/53; RR 4.23 95% CI 1.42–12.6). Regular cocaine use was associated with increased risk of operative debridement (4/6; RR 9.13 95% CI 2.33–35.8). A nonsignificant risk of operative debridement occurred with tobacco use (RR 1.14 95%CI 0.99–1.31 p = 0.09). Time to antivenom did not correlate with risk of necrosis. Conclusion: UE RSE patients who presented with cyanosis, ecchymosis or history of ethanol use were at increased risk of developing necrosis. Cocaine use was associated with increased risk of operative debridement.

[1]  B. Lucke-Wold,et al.  Osteonecrosis of Interphalangeal Joint of Thumb Two Months after Rattlesnake Bite. , 2015, Hand surgery : an international journal devoted to hand and upper limb surgery and related research : journal of the Asia-Pacific Federation of Societies for Surgery of the Hand.

[2]  H. Langstein,et al.  Serum Cotinine Concentration and Wound Complications in Head and Neck Reconstruction , 2008, Plastic and reconstructive surgery.

[3]  J. Gutiérrez,et al.  Trends in snakebite envenomation therapy: scientific, technological and public health considerations. , 2007, Current pharmaceutical design.

[4]  A. Rodríguez-Acosta,et al.  On the unsual hemorrhagic and necrotic activities caused by the rattlesnake (Crotalus durissus cumanensis) in a Venezuelan patient. , 2003, Revista cubana de medicina tropical.

[5]  B. Shaw,et al.  Rattlesnake Bites in Children: Antivenin Treatment and Surgical Indications , 2002, The Journal of bone and joint surgery. American volume.

[6]  M. L. Lebrão,et al.  Prognostic factors for local necrosis in Bothrops jararaca (Brazilian pit viper) bites. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  R. Clark,et al.  A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. , 2001, Archives of internal medicine.

[8]  R. Dart,et al.  Efficacy, safety, and use of snake antivenoms in the United States. , 2001, Annals of emergency medicine.

[9]  D. Tanen,et al.  Epidemiology and hospital course of rattlesnake envenomations cared for at a tertiary referral center in Central Arizona. , 2001, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[10]  J. Gutiérrez,et al.  Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA. , 2000, The American journal of tropical medicine and hygiene.

[11]  W. Hayes,et al.  Effects of a negative pressure venom extraction device (Extractor) on local tissue injury after artificial rattlesnake envenomation in a porcine model. , 2000, Wilderness & environmental medicine.

[12]  R. Álvarez,et al.  Rattlesnake bite complications in 19 children. , 1994, Pediatric emergency care.

[13]  M. Moneim,et al.  New Mexico rattlesnake bites: demographic review and guidelines for treatment. , 1991, The Journal of trauma.

[14]  C. Okerberg,et al.  Preliminary observations on the effects of hyperbaric oxygen therapy on western diamondback rattlesnake (Crotalus atrox) venom poisoning in the rabbit model. , 1989, Annals of emergency medicine.

[15]  C. Ownby,et al.  In vivo ability of antimyotoxin a serum plus polyvalent (Crotalidae) antivenom to neutralize prairie rattlesnake (Crotalus viridis viridis) venom. , 1986, Toxicon : official journal of the International Society on Toxinology.

[16]  D. L. Hardy Envenomation by the Mojave rattlesnake (Crotalus scutulatus scutulatus) in southern Arizona, U.S.A. , 1983, Toxicon : official journal of the International Society on Toxinology.

[17]  G. Omer,et al.  The management of upper extremity pit viper wounds. , 1980, The Journal of hand surgery.

[18]  T. Davidson,et al.  Rattlesnake bites: current concepts. , 1979, Clinical orthopaedics and related research.

[19]  H. W. Ramsey,et al.  Antivenin and Antitoxin in the Treatment of Experimental Rattlesnake Venom Intoxication. (Crotalus adamanteus). , 1961 .

[20]  D. Jackson,et al.  Mechanical Treatment of Experimental Rattlesnake Venom Poisoning. , 1928 .